Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
about
Epidemiology of esophageal cancerThe mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trialsBOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Obesity-Related Digestive Diseases and Their PathophysiologyThe tumor microenvironment in esophageal cancerBarrett's oesophagus: frequency and prediction of dysplasia and cancerAssociation of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-AnalysisMetabolic syndrome is associated with increased risk of Barrett esophagus: A meta-analysis.Obesity and cancer pathogenesis.Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studiesAssociations among Metabolism, Circadian Rhythm and Age-Associated DiseasesPhysical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis.A multibiomarker risk score helps predict risk for Barrett's esophagus.Symptomatic reflux disease: the present, the past and the future.Gastrointestinal morbidity in obesity.Circulating Inflammatory Cytokines Are Associated With the Risk of Barrett's Esophagus in Western Persons.The role of obesity in oesophageal cancer development.Molecular markers and imaging tools to identify malignant potential in Barrett's esophagusPathophysiological mechanisms linking obesity and esophageal adenocarcinomaPolymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.Republished: symptomatic reflux disease: the present, the past and the future.Mechanisms of obesity-induced gastrointestinal neoplasiaMetabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.The feasibility of an exercise intervention in males at risk of oesophageal adenocarcinoma: a randomized controlled trial.Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent LiteratureMetformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.Precision prevention of oesophageal adenocarcinoma.Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett's esophagusEpidemiology, Diagnosis, and Management of Esophageal AdenocarcinomaThe association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomyInfluence of obesity and bariatric surgery on gastric cancer.Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagusCirculating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control studyRisk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillanceProgression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewThe role of inflammation in cancer of the esophagus.A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity.
P2860
Q24625927-065248AC-687A-4CE2-ABB5-8E9FCE0EA150Q26751155-B34C6FFD-A535-48D3-9F79-31406FCA1245Q27332349-D9960969-7CC9-4751-BEC2-002825E05CCEQ28073381-CDC9FEB4-44EE-4279-B1BC-5F1070F5E90DQ28077074-D9ECAA22-4C9F-4020-B29A-67177F6845C2Q28080794-4257A363-4517-478D-ABA4-3689D14B84E7Q28087021-BF159F3D-FB1E-430B-9CCF-DD77E3F43EBBQ30248613-D16CF94F-08E8-4C47-843B-66B21F94D822Q30361298-29D4415D-8785-4615-80A4-03B58ABA6182Q33661718-1D32F27A-2E25-4FA4-8275-FC3BC3322DCBQ33714257-74635617-E69D-4598-B19A-02EB8D7819B5Q33756930-8B793D91-EB40-458D-BFA9-856D45349E37Q33779408-FCAFFE95-0311-4A00-8086-5FCBC84A9606Q33834731-A039C819-24CA-443B-843E-840D9625BA27Q34006048-E1213ABC-ED5B-448E-8FF4-6CDCBF329E17Q34377218-E8DCFC92-700B-40FF-AEED-560A472EDC21Q34418740-85EE9927-DDF8-4A27-ACA0-638982102615Q34508850-5FA7D41A-0C8D-4B2E-B48F-E2B4D708F430Q34508880-07B2CA0C-05E9-4608-9EB7-6B66091DCF3EQ35042479-E7B83F51-46F0-4412-827A-DCE912F9BA81Q35048270-4AEBC9EC-AED8-4F8A-BFE6-60CD7F83D785Q35062195-1C99C2B7-2E4E-4043-8E45-5A97EAA84D52Q35096812-F4F95419-C7CA-45E4-B4AE-356DFFD55A9CQ35113330-B750D4AF-656D-425F-A138-ECFC7CA3DE44Q35146950-E24FB793-D862-47E2-9EA5-EEE9B8D84456Q35185711-B86ACB84-41A8-4284-A39F-ABA0E2232CF2Q35243217-B4FCFEBB-2E87-4D57-819B-4217BCAC9A95Q35622201-B028BDF6-3A5C-40C7-BEFC-B9249D0EF9E2Q35778939-27B91F9A-9E2C-434B-8B00-0E10C405C502Q35893814-F69BCEF1-0B40-4285-8245-262440A4532BQ36080375-E8FCC7F5-B777-4917-8D09-4F4904219328Q37094067-ECEAA198-AE3F-44EF-986F-4FECB52CB303Q37228444-BCFF942F-026B-45E0-99DC-A3CA922E3683Q37505223-96F243C3-F9E0-49ED-A163-79E3E3F48DBFQ37538933-FEF6EE24-BA06-4F85-8C25-274E25D8121CQ37542809-78C0F13F-4D89-40E3-A183-B7C2B1C510BAQ38214324-CDB06CA3-99A5-47B6-8922-B3D87FF0193EQ38368081-BB29FECD-DF9E-4804-B3F5-C63413FDA3CDQ38402463-430A8162-5206-405C-9DDA-44148124069AQ38465754-C9ED8A90-0C78-4576-87AA-C5D722B21C29
P2860
Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between markers of ...... to esophageal adenocarcinoma.
@en
Association between markers of ...... to esophageal adenocarcinoma.
@nl
type
label
Association between markers of ...... to esophageal adenocarcinoma.
@en
Association between markers of ...... to esophageal adenocarcinoma.
@nl
prefLabel
Association between markers of ...... to esophageal adenocarcinoma.
@en
Association between markers of ...... to esophageal adenocarcinoma.
@nl
P2093
P2860
P1476
Association between markers of ...... s to esophageal adenocarcinoma
@en
P2093
Brian J Reid
Lynn Onstad
Sheetal Hardikar
Thomas L Vaughan
P2860
P304
P356
10.1016/J.CGH.2013.02.017
P407
P577
2013-03-01T00:00:00Z